Protein characteristics of thrombopoietin

Stem Cells

Volumn 14, Issue SUPPL. 1, 1996, Pages 139-147

  Kato, Takashi ^a  

^a KIRIN BREWERY CO LTD   (Japan)

Author keywords

c Mpl ligand; Cytokines; Disulfide bonds; Megakaryocyte; Plasma protein; Platelet; Protein structure; Purification; Thrombopoietin

Indexed keywords

COMPLEMENTARY DNA; DISULFIDE; RECOMBINANT PROTEIN; THROMBOPOIETIN;

ANIMAL; BLOOD; CELL CULTURE; CELL STRAIN COS1; CHEMISTRY; DOG; GEL CHROMATOGRAPHY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MOUSE; MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN TERTIARY STRUCTURE; RAT; REVIEW;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CHROMATOGRAPHY, GEL; COS CELLS; DISULFIDES; DNA, COMPLEMENTARY; DOGS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; LIVER; LIVER NEOPLASMS; MICE; MUTATION; PROTEIN STRUCTURE, TERTIARY; RATS; RECOMBINANT PROTEINS; THROMBOPOIETIN; TUMOR CELLS, CULTURED;

EID: 0030307679     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.5530140718     Document Type: Article

References (63)

1. Yamamoto S. Mechanism of the development of thrombocytosis due to bleeding. Acta Haematol Jpn 1957;20:163-178.
2. Keleman E, Cserhati I, Tanos B. Demonstration and some properties of human thrombopoietin. Acta Haematol 1958;20:350-355.
3. Odell TT, McDonald TP, Detwiler TC. Stimulation of platelet production by serum of platelet-depleted rats. Proc Soc Exp Biol Med 1961;108:428-431.
4. Evatt BL, Shreiner DP, Levin J. Thrombopoietic activity of fractions of rabbit plasma: studies in rabbits and mice. J Lab Clin Med 1974;83:364-371.
5. McDonald TP, Cottrell M, Clift R. Hematologic changes and thrombopoietin production in mice after X-irradiation and platelet-specific antisera. Exp Hematol 1977;5:291-298.
6. Miyake T, Kawakita M, Enomoto K et al. Partial purification and biological properties of thrombopoietin extracted from the urine of aplastic anemia patients. Int J Cell Cloning 1982;2:129-144.
7. Kawakita M, Miyake T, Kishimoto S et al. Apparent heterogeneity of human megakaryocyte colony- and thrombopoiesis-stimulating factors: studies on urinary extracts from patients with aplastic anaemia and idiopathic thrombocytopenic purpura. Br J Haematol 1982;52:429-438.
8. Kawakita M, Ogawa M, Goldwasser E et al. Characterization of human megakaryocyte colony-stimulating factor in the urinary extracts from patients with aplastic anemia and idiopathic thrombocytopenic purpura. Blood 1983;61:556-560.
9. Miura M, Jackson CW, Lyles SA. Increases in circulating megakaryocyte growth-promoting activity in the plasma of rats following whole body irradiation. Blood 1984;63:1060-1066.
10. Mazur EM, South K. Human megakaryocyte colony-stimulating factor in sera from aplastic dogs: partial purification, characterization and determination of hematopoietic cell lineage specificity. Exp Hematol 1985;13:1164-1172.
11. Hoffman R, Yang HH, Bruno E et al. Purification and partial characterization of a megakaryocyte colony-stimulating factor from human plasma. J Clin Invest 1985;75:1174-1182.
12. Hill R, Levin J. Partial purification of thrombopoietin using lectin chromatography. Exp Hematol 1986;14:752-759.
13. McDonald TP, Clift RC, Cottrell MB. A four-step procedure for the purification of thrombopoietin. Exp Hematol 1989;17:865-871.
14. Erickson-Miller CL, Parchment RE, Zhang ZG et al. Purification of human megakaryocyte colony-stimulating factor (Meg-CSF) from urine of aplastic anemia patients. In: Murphy, MJ Jr, ed. Blood Cell Growth Factors: Their Present and Future Use in Hematology and Oncology. Dayton, OH: AlphaMed Press, 1992:204-220.
15. Hill RJ, Levin J, Levin FC. Correlation of in vitro and in vivo biological activities during the partial purification of thrombopoietin. Exp Hematol 1992;20:354-360.
16. de Sauvage FJ, Hass PE, Spencer SD et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994;369:533-538.
17. Lok S, Kaushansky K, Holly RD et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994;369:565-568.
18. Kato T, Ogami K, Shimada Y et al. Purification and characterization of thrombopoietin. J Biochem 1995;118:229-236.
19. Hunt P, Li L, Nichol JL et al. Purification and biological characterization of plasma-derived megakaryocyte growth and development factor (MGDF). Blood 1995;86:540-547.
20. Kuter DJ, Beeler DL, Rosenberg RD. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci USA 1994;91:11104-11108.
21. Miyazaki H, Inoue H, Yanagida M et al. Purification of rat megakaryocyte colony forming cells using a monoclonal antibody against rat platelet glycoprotein IIb/IIIa. Exp Hematol 1992;20:855-861.
22. Miyazaki H, Horie K, Shimada Y et al. A simple and quantitative liquid culture system to measure megakaryocyte growth using highly purified CFU-Mk. Exp Hematol 1995;23:1224-1228.
23. Bartley TD, Bogenberger J, Hunt P et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994;77:1117-1124.
24. Ogami K, Shimada Y, Sohma Y et al. The sequence of a rat cDNA encoding thrombopoietin. Gene 1995;158:309-310.
25. Sohma Y, Akahori H, Seki N et al. Molecular cloning and chromosomal localization of human thrombopoietin gene. FEBS Lett 1994;353:57-61.
26. Shimada T, Kato T, Ogami K et al. Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell lines. Exp Hematol 1995;23:1388-1396.
27. Kaushansky K, Lok S, Holly RD et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 1994;369:568-571.
28. Wendung F, Maraskovsky E, Debili N et al. c-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 1994;369:571-574.
29. Lok S, Foster DC. The structure, biology and potential therapeutic applications of recombinant thrombopoietin. STEM CELLS 1994;12:586-598.
30. Gurney AL, Carver-Moore K, de Sauvage FJ et al. Thrombocytopenia in c-mpl-deficient mice. Science 1994;265:1445-1447.
31. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995;86:419-431.
32. Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 1995;85:2720-2730.
33. Nichol JL, Hokom MM, Hornkohl A et al. Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. J Clin Invest 1995;95:2973-2978.
34. Choi ES, Hokom M, Bartley T et al. Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro. STEM CELLS 1995;13:317-322.
35. Miyakawa Y, Oda A, Druker BJ et al. Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood platelets. Blood 1995;86:23-27.
36. Matsumura I, Kanakura Y, Kato T et al. Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. Blood 1995;86:703-709.
37. Kobayashi M, Laver JH, Kato T et al. Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors. Blood 1995;86:2494-2499.
38. Foster DC, Sprecher CA, Grant FJ et al. Human thrombopoietin: gene structure, cDNA sequence, expression and chromosomal localization. Proc Natl Acad Sci USA 1994;91:13023-13027.
39. Chang MS, McNinch J, Basu RJ et al. Cloning and characterization of the human megakaryocyte growth and development factor (MGDF) gene. J Biol Chem 1995;270:511-514.
40. Chang MS, Hsu RY, McNinch J et al. The gene for murine megakaryocyte growth and development factor (thrombopoietin, Tpo) is located on mouse chromosome 16. Genomics 1995;26:636-637.
41. Tahara T, Usuki K, Sato H et al. A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders. Brit J Haematol 1996;93:783-788.
42. Iwamatsu A. S-carboxymethylation of proteins transferred onto polyvinylidene difluoride membranes followed by in situ protease digestion and amino acid microsequencing. Electrophoresis 1992;13:142-147.
43. Lin FK, Suggs S, Lin CH et al. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci USA 1985;82:7580-7584.
44. Jacobs K, Shoemaker C, Rudersdorf R et al. Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 1985;313:806-810.
45. Hirano T, Yasukawa K, Harada H et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986;324:73-76.
46. May LT, Helfgott DC, Sehgal PB. Anti-beta-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the beta 2 interferon involved. Proc Natl Acad Sci USA 1986;83:8957-8961.
47. Paul SR, Bennett F, Calvetti JA et al. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA 1990;87:7512-7516.
48. Kawashima I, Ohsumi J, Mita-Honjo K et al. Molecular cloning of cDNA encoding adipogenesis inhibitory factor and identity with interleukin 11. FEBS Lett 1991;283:199-202.
49. Yang YC, Ciarletta AB, Temple PA et al. Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3. Cell 1986;47:3-10.
50. Otsuka T, Miyajima A, Brown N et al. Isolation and characterization of an expressible cDNA encoding human IL-3. Induction of IL-3 mRNA in human T cell clones. J Immunol 1988;140:2288-2295.
51. Miyatake S, Otsuka T, Yokota T et al. Structure of the chromosomal gene for granulocyte-macrophage colony stimulating factor: comparison of the mouse and human genes. EMBO J 1985;4:2561-2568.
52. Lee F, Yokota T, Otsuka T et al. Isolation of cDNA for a human granulocyte-macrophage colony-stimulating factor by functional expression in mammalian cells. Proc Natl Acad Sci USA 1985;82:4360-4364.
53. Nagata S, Tsuchiya M, Asano S et al. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 1986;319:415-418.
54. Souza LM, Boone TC, Gabrilove J et al. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 1986;232:61-65.
55. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976;13:29-83.
56. Kato T, Ozawa T, Muto T et al. Essential structure for biological activity of thrombopoietin. Blood 1995;86:365a.
57. Avanzi GC, Brizzi MF, Giannotti J et al. M-07e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3. J Cell Physiol 1990;145:458-464.
58. Wada T, Nagata Y, Nagahisa H et al. Characterization of the truncated thrombopoietin variants. Biochem Biophys Res Commun 1995;213:1091-1098.
59. Linden H, O'Rork C, Hart CE et al. The structural and functional role of disulfide bonding in thrombopoietin. Blood 1995;86:255a.
60. Boissel JP, Lee WR, Presnell SR et al. Erythropoietin structure-function relationships. Mutant proteins that test a model of tertiary structure. J Biol Chem 1993;268:15983-15993.
61. McDonald JD, Lin FK, Goldwasser E. Cloning, sequencing, and evolutionary analysis of the mouse erythropoietin gene. Mol Cell Biol 1986;6:842-848.
62. Shoemaker CB, Mitsock LD. Murine erythropoietin gene: cloning, expression, and human gene homology. Mol Cell Biol 1986;6:849-858.
63. Li B, Dai W. Thrombopoietin and neutrophins share a common domain. Blood 1995;86:1643-1644.